1. Home
  2. BIOA vs NOAH Comparison

BIOA vs NOAH Comparison

Compare BIOA & NOAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

N/A

Current Price

$16.51

Market Cap

776.6M

Sector

Health Care

ML Signal

N/A

NOAH

Noah Holdings Limited

N/A

Current Price

$10.03

Market Cap

653.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BIOA
NOAH
Founded
2015
2005
Country
United States
China
Employees
62
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
776.6M
653.4M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
BIOA
NOAH
Price
$16.51
$10.03
Analyst Decision
Strong Buy
Hold
Analyst Count
6
2
Target Price
$51.50
$11.00
AVG Volume (30 Days)
414.5K
184.1K
Earning Date
05-05-2026
05-27-2026
Dividend Yield
N/A
5.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$846.41
N/A
Revenue Next Year
N/A
$5.71
P/E Ratio
N/A
$13.29
Revenue Growth
N/A
N/A
52 Week Low
$3.66
$8.38
52 Week High
$24.00
$12.84

Technical Indicators

Market Signals
Indicator
BIOA
NOAH
Relative Strength Index (RSI) 41.58 37.63
Support Level $15.47 $9.64
Resistance Level $18.65 $10.72
Average True Range (ATR) 1.03 0.38
MACD -0.03 0.02
Stochastic Oscillator 30.56 26.98

Price Performance

Historical Comparison
BIOA
NOAH

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

About NOAH Noah Holdings Limited

Noah Holdings Ltd is a wealth management service provider offering comprehensive advisory services on investment and asset allocation, mainly for Mandarin-speaking high-net-worth (HNW) investors. The company's operating segments are Domestic public securities, Domestic asset management, Domestic insurance, Overseas wealth management, Overseas asset management, Overseas insurance and comprehensive services, and Headquarters. Maximum revenue is generated from its Domestic asset management business, which manages private equity funds, real estate equity funds, and private secondary products. The domestic asset management operations focus on managing primary market exits and cross-border ETF products in the secondary market. Geographically, it derives maximum revenue from Mainland China.

Share on Social Networks: